The Remarkable Journey of Fondaparinux – Abdul Mannan
Dr. Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
“The Remarkable Journey of Fondaparinux:
The story begins with Jay McLean’s accidental discovery of heparin at Johns Hopkins in 1916. Decades later, Harvard and Uppsala scientists revealed heparin’s mechanism – supercharging antithrombin by 1000-fold.
The Breakthrough (1980s):
Researchers discovered a pentasaccharide sequence within heparin was responsible for anticoagulation – The exact key that unlocks antithrombin’s potential.The Innovation (1987):
Maurice Petitou’s team at Institut Choay achieved the impossible – synthesizing the first artificial pentasaccharide (SR90107A/Org31540): The fondaparinux.Clinical Success (2002):
Trials involving 7,000+ patients, fondaparinux (Arixtra) showed 55% RR reduction in VTE. Sanofi brought this revolutionary anticoagulant to market.Why It Matters:
– Selective Xa inhibition
– No HIT risk
– Fixed dosing , no monitoring
– Synthetic precision over natural variabilityThis journey shows how molecular insight transforms patient care. Fondaparinux remains key in VTE prevention and led to modern anticoagulants.
What breakthrough in hemostasis research inspires you most?”
Don’t miss the latest updates with Hemostasis Today.
-
Apr 18, 2026, 15:24Jeyaraj Pandian: Stroke Is No Longer an Inevitable Sentence to Death or Lifelong Disability
-
Apr 18, 2026, 15:24Megan Adediran: World Haemophilia Day Is More Than a Date on the Calendar
-
Apr 18, 2026, 15:10Owen McCarty։ Honored to Deliver the Bell Lectureship at Johns Hopkins University
-
Apr 18, 2026, 15:04Rene Staebe: Dare to Care in Hemophilia – When Small Acts Change Lives
-
Apr 18, 2026, 14:31Abeer Alanazi: New Stroke Prevention Without Increased Bleeding Risk
-
Apr 18, 2026, 14:28Krishnakant Prasad: Hemodynamic Stress and Arterial Wall Integrity in Aneurysm Formation
-
Apr 18, 2026, 13:57Arwa Z. Al-Riyami: Shaping the Future of Transfusion Medicine Through Artificial Intelligence
-
Apr 18, 2026, 13:37Bridget Flynn: An Opportunity to Support Medication Management for Stroke Survivors
-
Apr 18, 2026, 13:16Mohammed M. Aboudeif: The Decision-Making Process for Anticoagulation in Stroke